PET-degrading enzyme PET-mh 29 / 124 / 183 Mutant and its encoding gene, engineered bacteria and application

By mutation of the amino acid sequence of PET degrading enzyme at specific sites, the PET-mh29/124/183 mutant was formed, which solved the problems of poor enzyme stability and low catalytic efficiency in the prior art, and achieved efficient degradation of different crystallinity degrees PET waste, simplifying process and reducing costs.

CN117264927BActive Publication Date: 2024-11-29YUANTIAN BIOTECHNOLOGY (TIANJIN) CO LTD

Patent Information

Application Number
CN202311208970.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-09-19
Publication Date
2024-11-29
Estimated Expiration
2043-09-19

AI Technical Summary

Technical Problem

When the prior art degradation of PET using biodegradation method, the enzyme has poor stability, low catalytic efficiency, and the degradation process is complex and costly.

Method used

By mutation of the amino acid sequence of the PET degrading enzyme at a specific site, a PET-mh29/124/183 mutant was formed, which exhibited high-efficiency degradation ability on high crystallinity PET.

Benefits of technology

The PET-mh29/124/183 mutant has significantly improved degradation activity and catalytic efficiency, and can efficiently degrade PET waste with different crystallinity degrees, simplify the degradation process and reduce costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004456791800000071
    Figure BDA0004456791800000071
  • Figure BDA0004456791800000081
    Figure BDA0004456791800000081
Patent Text Reader

Abstract

The present invention belongs to the technical field of enzyme engineering and particularly relates to a PET-degrading enzyme PET-mh 29 / 124 / 183 Mutant and its encoding gene, recombinant plasmid, engineered bacteria and application. PET-degrading enzyme PET-mh provided by the present invention 29 / 124 / 183 The mutant is obtained by mutating the amino acids at positions 29, 124 and 183 in the protein with the amino acid sequence as shown in SEQ ID No. 1. Compared with the protein with the amino acid sequence as shown in SEQ ID No. 1, the mutant has a higher degradation efficiency for both low crystallinity and more difficult to degrade high crystallinity PET, and has high TPA and MHET yields, and can be used for scale conversion and monomer recovery of PET with different crystallinities. The present invention also provides a coding gene encoding the mutant, a recombinant plasmid containing the coding gene, an engineered bacterium containing the recombinant plasmid and applications thereof.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of enzyme engineering, and in particular to a PET degrading enzyme PET-mh 29 / 124 / 183 Mutants and their encoding genes, engineered bacteria and applications. Background Art

[0002] Polyethylene terephthalate (PET), commonly known as polyester resin, is the most important variety of thermoplastic polyester and one of the five major engineering plastics. PET has excellent chemical resistance, thermal stability and physical and mechanical properties in a wide temperature range, high impact strength, good folding resistance, low density, and is easy to process and use. It has been widely used in many fields such as packaging materials, insulation materials, and electronic appliances. However, while PET is widely used in large quantities, a large amount of waste PET materials is also generated. Since PET is difficult to degrade in the natural environment, the pollution problem caused by it is becoming more and more serious, which not only seriously harms the natural environment, but also poses a great threat to the safety and health of animals and humans.

[0003] At present, the methods for recycling PET waste mainly include physical recycling and chemical recycling, but the recycling process still causes secondary pollution to the environment and consumes a lot of energy and resources in the recycling process. The biodegradation method degrades PET into monomer molecules of terephthalic acid (TPA) and ethylene glycol by enzymes or microorganisms. It not only has low dependence on energy and resources, but also has a single degradation product, which is easy to recycle and reuse. It is a green and environmentally friendly method with development potential. However, there are problems such as poor enzyme stability and low catalytic efficiency in degrading PET by biodegradation. Through biosynthesis technology, researchers have obtained some PET degradation enzymes with relatively high degradation speeds and can obtain TPA monomers, but the process of degrading PET with these degradation enzymes requires high-temperature melt recrystallization and micronization of crushers to reduce the high crystallinity of PET and the influence of hydrophobic surface on PET enzymatic hydrolysis, which is complicated and costly. Summary of the invention

[0004] In view of the above technical problems, the present invention provides a PET degrading enzyme PET-mh 29 / 124 / 183 Mutant and its encoding gene, engineering bacteria and application, the PET degradation enzyme PET-mh 29 / 124 / 183 The mutant has higher degradation activity and can also efficiently degrade high-crystallinity PET, thereby simplifying the PET degradation process and reducing costs.

[0005] In order to achieve the above-mentioned object of the invention, the present invention adopts the following technical solutions:

[0006] In a first aspect, the present invention provides a PET degrading enzyme PET-mh 29 / 124 / 183A mutant, wherein the mutant is obtained by mutating the amino acids at positions 29, 124 and 183 in the protein with the amino acid sequence as shown in SEQ ID No. 1.

[0007] The protein with the amino acid sequence shown in SEQ ID No.1 has good degradation activity for PET degradation enzyme. Experiments have shown that the performance of the mutant obtained by mutating only the amino acids at positions 29, 124 and 183 is improved relative to the protein, and the synergistic effect can be obtained by mutating the amino acids at the above three sites. The activity of the obtained mutant is significantly better than that of the mutants in which the above three sites are mutated alone or two of the sites are mutated. It has a high degradation efficiency for both low-crystallinity and more difficult-to-degrade high-crystallinity PET, and has high TPA and MHET yields. Therefore, the PET degradation enzyme PET-mh provided by the present invention 29 / 124 / 183 The mutants can be used for scale conversion and monomer recovery of PET with different crystallinity.

[0008] In conjunction with the first aspect, it is preferred that the amino acid at position 29 is mutated to L-alanine.

[0009] In combination with the first aspect, it is preferred that the amino acid at position 124 is mutated to S-glycine.

[0010] In conjunction with the first aspect, it is preferred that the amino acid at position 183 is mutated to L-tyrosine.

[0011] In a second aspect, the present invention also provides the above-mentioned PET degrading enzyme PET-mh 29 / 124 / 183 Application of the mutant in hydrolyzing PET: adding the PET degrading enzyme PET-mh to a potassium phosphate buffer having a pH value of 7.5 to 8.5 and a concentration of 80 to 120 mM 29 / 124 / 183 The mutants were added to a final concentration of 5 to 15 μg / mL and PET degradation was performed at 65 to 75° C. and 100 to 220 rpm.

[0012] In a third aspect, the present invention also provides a method for encoding a PET-degrading enzyme PET-mh 29 / 124 / 183 Mutant gene, the PET-degrading enzyme PET-mh 29 / 124 / 183 The amino acid sequence of the mutant is shown in SEQ ID No.2, and the nucleotide sequence thereof is shown in SEQ ID No.3.

[0013] In a fourth aspect, the present invention also provides a recombinant plasmid containing the above nucleotide sequence.

[0014] In a fifth aspect, the present invention also provides a method for constructing the above-mentioned recombinant plasmid: using the above-mentioned nucleotide sequence as a template, a single point mutation is constructed using corresponding primers, the target gene is first exponentially amplified by a PCR reaction, and then the template chain is removed using the restriction endonuclease Dpn I, and the PCR product is quickly circularized using a DNA ligase to obtain a recombinant plasmid.

[0015] In a sixth aspect, the present invention also provides an engineered bacterium constructed using the above-mentioned recombinant plasmid.

[0016] In combination with the sixth aspect, the engineered bacteria is Escherichia coli.

[0017] In a seventh aspect, the present invention also provides a method for constructing the above-mentioned engineered bacteria: transforming the above-mentioned recombinant plasmid into BL21 (DE3) competent cells, spreading them on ampicillin plate culture medium, and obtaining positive recombinants, namely the engineered bacteria.

[0018] In an eighth aspect, the present invention also provides the use of the above-mentioned engineered bacteria in the degradation of PET.

[0019] Exemplarily, the method for degrading PET using the above-mentioned engineered bacteria can refer to the following operation: the above-mentioned engineered bacteria are cultured in LB liquid culture medium until the OD600 value reaches the range of 0.8-1.0, and the inducer IPTG (isopropyl β-D-1-thiogalactopyranoside) is added to a concentration of 0.1-0.15 mM, and the expression is induced at 15-17° C. for 20-24 hours;

[0020] The fermentation culture was centrifuged, resuspended by pipetting with a bacteria-breaking buffer, and centrifuged again to obtain the PET-degrading enzyme PET-mh 29 / 124 / 183 The crude enzyme solution of the mutant; the crude enzyme solution is concentrated after protein purification and used as a biocatalyst for degrading PET;

[0021] The PET film substrate to be degraded is added to the PET reaction solution, and a biocatalytic reaction is carried out at 65-75° C. The PET reaction solution contains a potassium phosphate buffer solution with a pH of 8.0 and a biocatalyst for degrading PET.

[0022] The beneficial effects of the present invention are as follows: the PET degrading enzyme PET-mh 29 / 124 / 183 The mutant has higher activity and high catalytic efficiency, and can effectively degrade PET waste with different crystallinity. It can be used for resource regeneration and secondary development of PET waste, thereby alleviating the pressure on petroleum resources required for PET production, solving the serious environmental pollution problem caused by PET waste, and improving the recycling value of PET. It has good application prospects. DETAILED DESCRIPTION

[0023] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0024] PET has excellent chemical resistance, thermal stability and physical and mechanical properties, high impact strength, good folding resistance, low density, easy processing and use. It has been widely used in many fields such as packaging materials, insulation materials, electronic appliances, etc., but it has produced a large amount of PET waste that is difficult to degrade and seriously pollutes the environment. Compared with physical and chemical methods, biological methods use enzymes or microorganisms to degrade PET into monomer molecules terephthalic acid (TPA) and ethylene glycol. It is green and environmentally friendly and has development potential. However, there are problems such as poor enzyme stability and low catalytic efficiency in the process of biological degradation of PET plastics.

[0025] Modifying the amino acid sequence of an enzyme is a common way to obtain new functions, but not all modifications can produce mutants with ideal functions.

[0026] In order to solve the above problems, the present invention provides a PET degrading enzyme PET-mh 29 / 124 / 183 A mutant, wherein the mutant is obtained by mutating the amino acids at positions 29, 124 and 183 in the amino acid sequence shown in SEQ ID No. 1.

[0027] The embodiment of the present invention also provides the above-mentioned PET degrading enzyme PET-mh 29 / 124 / 183 Construction method of mutants and their application in hydrolysis of PET.

[0028] The embodiment of the present invention also provides a gene encoding the mutant, and its nucleotide sequence is shown in SEQ ID No.2.

[0029] The embodiments of the present invention also provide a recombinant plasmid containing the above nucleotide sequence and a construction method thereof, as well as an engineered bacterium constructed using the recombinant plasmid.

[0030] The embodiment of the present invention also provides a method for constructing the engineered bacteria and its application in degrading PET.

[0031] The scheme of the present invention is described below through specific embodiments.

[0032] Unless otherwise specified, the reagents in the following examples are commercially available or obtained according to methods known in the art.

[0033] Example 1

[0034] The embodiment of the present invention provides a PET degrading enzyme PET-mh 29 / 124 / 183A mutant, wherein the L-serine at position 29 in the amino acid sequence shown in SEQ ID No. 1 is mutated to L-alanine, the L-leucine at position 124 is mutated to S-glycine, and the L-histidine at position 183 is mutated to L-tyrosine. The amino acid sequence of the obtained mutant is shown in SEQ ID No. 2, and the nucleotide sequence is shown in SEQ ID No. 3.

[0035] Example 2

[0036] The present invention provides the PET degrading enzyme PET-mh in Example 1. 29 / 124 / 183 Application of mutants in hydrolysis of PET:

[0037] The PET to be degraded was used as a substrate, and the PET-degrading enzyme PET-mh prepared in Example 1 was added to 300 μL of potassium phosphate buffer having a pH value of 8. 29 / 124 / 183 The mutants were added to a final concentration of 500 nM and PET degradation was performed in a water bath at 60-75°C.

[0038] Example 3

[0039] The present invention provides a method for encoding the PET degrading enzyme PET-mh 29 / 124 / 183 Recombinant plasmid of mutant gene and construction method:

[0040] To encode the PET degrading enzyme PET-mh in Example 1 29 / 124 / 183 The nucleotide sequence of the mutant was used as a template, and the corresponding primers were used to construct a single point mutation. The target gene was first exponentially amplified by PCR reaction, and then the template chain was removed by restriction endonuclease Dpn I. The PCR product was then rapidly cyclized by DNA ligase to obtain a gene encoding the PET degrading enzyme PET-mh 29 / 124 / 183 Recombinant plasmid containing the mutant gene.

[0041] Example 4

[0042] The present invention provides an engineering bacterium containing the recombinant plasmid of Example 3 and a method for constructing the same:

[0043] The recombinant plasmid of Example 3 was transformed into BL21 (DE3) (full gold, CD601) competent cells and spread on ampicillin plate culture medium to obtain positive recombinants, which are the engineered bacteria containing the recombinant plasmid of Example 3.

[0044] Example 5

[0045] The present invention provides an application of the engineering bacteria in Example 4 in the degradation of PET:

[0046] The E. coli engineered bacteria constructed in Example 4 were first cultured in 5 mL LB liquid medium (containing 100 mg / L ampicillin resistance) for 12-16 h, and then transferred to a shake flask at a 1% inoculum for culture. When the OD600 value reached the range of 0.8-1.0, the inducer IPTG (isopropyl β-D-1-thiogalactopyranoside) was added to a concentration of 0.1 mM, and the expression was induced at 16°C for 22 h.

[0047] The fermentation culture was centrifuged at 4000 rpm for 20 min to obtain the PET-mh 29 / 124 / 183 The mutant bacterial slurry was resuspended by pipetting in a lysis buffer (each liter of lysis buffer contained 50 mM Tris-HCl, 150 mM NaCl and 10 mM imidazole, pH = 7.5), and the cells were ruptured by an ultra-high pressure continuous flow cell disruptor to obtain a ruptured bacterial solution. The ruptured bacterial solution was centrifuged at 4°C and 10,000 rpm for 1 hour, and the supernatant was taken to obtain a PET-mh 29 / 124 / 183 Crude enzyme solution of mutant. The crude enzyme solution was filtered with a 0.45 μm filter membrane, mixed with the Ni medium, and placed in a 4°C, 180 rpm full-temperature shaking incubator for at least 1 hour. Then the protein was purified by Ni-NTA column, first washed with a wash buffer (each liter of wash buffer contains 50 mM Tris-HCl, 150 mM NaCl and 20 mM imidazole, pH = 7.5) to remove impurities, and then eluted with an elution buffer (each liter of elution buffer contains 50 mM Tris-HCl, 300 mM NaCl and 300 mM imidazole, pH = 7.5), and the eluted liquid was collected, i.e., the protein purified solution. The protein purified solution was concentrated to a concentration of 5 mg / mL through a protein concentrator tube, collected and stored in a 4°C refrigerator. It was then added to the catalytic system (final concentration: 10 μg / mL) as a biocatalyst for degrading PET.

[0048] Take the PET substrate to be degraded and add it to 300 μL of PET reaction solution (each liter of PET reaction solution contains 100 mM potassium phosphate buffer, pH = 8.0, add PET-mh 29 / 124 / 183 The mutant protein was added to a final concentration of 10 μg / mL) and placed at 65-75°C for biocatalytic reaction.

[0049] Comparative Example 1

[0050] This comparative example provides a PET degradation enzyme mutant, in which the L-serine at position 29 in the amino acid sequence shown in SEQ ID No. 1 is mutated to L-alanine.

[0051] Comparative Example 2

[0052] This comparative example provides a PET degradation enzyme mutant, in which the L-leucine at position 124 in the amino acid sequence shown in SEQ ID No. 1 is mutated to S-glycine.

[0053] Comparative Example 3

[0054] This comparative example provides a PET degradation enzyme mutant, in which the L-histidine at position 183 in the amino acid sequence shown in SEQ ID No. 1 is mutated to L-tyrosine.

[0055] Comparative Example 4

[0056] This comparative example provides a PET degradation enzyme mutant, in which the L-leucine at position 124 in the amino acid sequence shown in SEQ ID No. 1 is mutated to S-glycine, and the L-histidine at position 183 is mutated to L-tyrosine.

[0057] Comparative Example 5

[0058] This comparative example provides a PET degrading enzyme mutant, in which the L-aspartic acid at position 63 in the amino acid sequence shown in SEQ ID No. 1 is mutated to L-threonine, the L-leucine at position 124 is mutated to S-glycine, and the L-histidine at position 183 is mutated to L-tyrosine.

[0059] Test example

[0060] The method of Example 2 was used to examine the protein with the amino acid sequence shown in SEQ ID No. 1 and the PET degrading enzyme PET-mh in Example 1. 29 / 124 / 183 The effects of mutants and PET degradation enzyme mutants of comparative examples 1 to 5 on the degradation of PET with different crystallinity for 5 hours.

[0061] Using PET with different crystallinity as substrate, a protein with an amino acid sequence as shown in SEQ ID No. 1, a PET degrading enzyme PET-mh of Example 1 and a 300 μL potassium phosphate buffer having a pH of 8 were added. 29 / 124 / 183 The mutant or the PET degrading enzyme mutant of Comparative Examples 1 to 5 was used as a PET reaction solution to degrade PET in a water bath at 60-75° C. After 5 h of reaction, methanol was added to terminate the reaction, and the generated amounts of TPA, BHET and MHET were tested by reverse phase HPLC.

[0062] The results are shown in Table 1.

[0063] Table 1 TPA, BHET and MHET generation

[0064]

[0065]

[0066] From the above results, it can be seen that by mutating the amino acids at positions 29, 124 and 183 together, the mutants obtained can achieve a more ideal degradation effect on both low-crystalline and high-crystalline PET within 5 hours of degradation.

[0067] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent substitution or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A PET-degrading enzyme PET-mh 29 / 124 / 183 A mutant characterized in that The PET-degrading enzyme PET-mh 29 / 124 / 183 The mutant is obtained by mutating the amino acids at positions 29, 124 and 183 in the amino acid sequence shown in SEQ ID No. 1; Among them, the amino acid at position 29 was mutated to L-alanine; The amino acid at position 124 was mutated to S-glycine; The amino acid at position 183 was mutated to L-tyrosine.

2. The PET degrading enzyme PET-mh according to claim 1 29 / 124 / 183 The use of the mutant in hydrolyzing PET is characterized in that: The PET degrading enzyme PET-mh is added to a potassium phosphate buffer having a pH value of 7.5 to 8.5 and a 80 to 120 mM solution. 29 / 124 / 183 The mutants were added to a final concentration of 5-15 μg / mL and PET degradation was performed at 65-75°C and 100-220 rpm.

3. Encoding PET-degrading enzyme PET-mh 29 / 124 / 183 A mutant gene, characterized in that The PET-degrading enzyme PET-mh 29 / 124 / 183 The amino acid sequence of the mutant is shown in SEQ ID No.2, and the nucleotide sequence thereof is shown in SEQ ID No.

3.

4. A recombinant plasmid containing the nucleotide sequence of claim 3.

5. The method for constructing a recombinant plasmid according to claim 4, characterized in that: Using the nucleotide sequence described in claim 4 as a template, a single point mutation is constructed using corresponding primers, the target gene is first exponentially amplified by PCR reaction, and then the template chain is removed by restriction endonuclease Dpn I, and then the PCR product is quickly cyclized using DNA ligase to obtain a recombinant plasmid.

6. An engineered bacterium constructed using the recombinant plasmid according to claim 5.

7. The engineered bacteria according to claim 6, characterized in that The engineered bacteria is Escherichia coli.

8. The method for constructing the engineered bacteria according to claim 7, characterized in that: The recombinant plasmid described in claim 5 is transformed into BL21 (DE3) competent cells, and spread on ampicillin plate culture medium to obtain positive recombinants, which are the engineered bacteria.

9. Use of the engineered bacteria according to claim 6 or 7 in degrading PET.

Citation Information

Patent Citations

  • Esterases and uses thereof

    CA3030470A1

  • Fusion protein and application of fusion protein in degrading polymers

    CN112159478A

  • Novel esterases and uses thereof

    CN112673104A

  • PET hydrolase IsPETase mutant enzyme, coding gene and engineering bacterium

    CN113774041A

  • Cutinase variant as well as preparation method and application thereof in plastic degradation

    CN116286727A

Cited By

  • Method for preparing hydrophobic PET (Polyethylene Terephthalate) fabric by enzymatic method and fabric

    CN122327547A